These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17915278)

  • 21. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.
    Morrison LA; Zhu L; Thebeau LG
    J Virol; 2001 Feb; 75(3):1195-204. PubMed ID: 11152492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
    Hoshino Y; Dalai SK; Wang K; Pesnicak L; Lau TY; Knipe DM; Cohen JI; Straus SE
    J Virol; 2005 Jan; 79(1):410-8. PubMed ID: 15596834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus-encoded b7-2 costimulation molecules enhance the protective capacity of a replication-defective herpes simplex virus type 2 vaccine in immunocompetent mice.
    Vagvala SP; Thebeau LG; Wilson SR; Morrison LA
    J Virol; 2009 Jan; 83(2):953-60. PubMed ID: 18987142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.
    Smith TJ; Ackland-Berglund CE; Leib DA
    J Virol; 2000 Apr; 74(8):3598-604. PubMed ID: 10729135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.
    Parker ZM; Pasieka TJ; Parker GA; Leib DA
    J Virol; 2016 Dec; 90(23):10789-10799. PubMed ID: 27681121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.
    Augustinova H; Hoeller D; Yao F
    J Virol; 2004 Jun; 78(11):5756-65. PubMed ID: 15140973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy.
    Pepose JS; Keadle TL; Morrison LA
    Am J Ophthalmol; 2006 Mar; 141(3):547-557. PubMed ID: 16490506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.
    Alekseev O; Donovan K; Azizkhan-Clifford J
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):706-15. PubMed ID: 24370835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.
    Richards CM; Case R; Hirst TR; Hill TJ; Williams NA
    J Virol; 2003 Jun; 77(12):6692-9. PubMed ID: 12767989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2.
    Burn C; Ramsey N; Garforth SJ; Almo S; Jacobs WR; Herold BC
    J Infect Dis; 2018 Feb; 217(5):754-758. PubMed ID: 29216362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection.
    Egan KP; Hook LM; Naughton A; Pardi N; Awasthi S; Cohen GH; Weissman D; Friedman HM
    PLoS Pathog; 2020 Jul; 16(7):e1008795. PubMed ID: 32716975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10).
    Aurelian L; Kokuba H; Smith CC
    Vaccine; 1999 Apr; 17(15-16):1951-63. PubMed ID: 10217594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
    Osorio Y; Ghiasi H
    J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes. Vaccines for HSV.
    Stanberry LR
    Dermatol Clin; 1998 Oct; 16(4):811-6, xiv. PubMed ID: 9891686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An M2 Rather than a T
    Lee DH; Ghiasi H
    J Virol; 2018 May; 92(10):. PubMed ID: 29491152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner.
    Edwards RG; Kopp SJ; Karaba AH; Wilcox DR; Longnecker R
    mBio; 2015 Oct; 6(5):e01532-15. PubMed ID: 26489863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis.
    Naidu SK; Nabi R; Cheemarla NR; Stanfield BA; Rider PJ; Jambunathan N; Chouljenko VN; Carter R; Del Piero F; Langohr I; Kousoulas KG
    PLoS One; 2020; 15(2):e0228252. PubMed ID: 32027675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.